In Phase 2 trials, the heart rate increases were not associated with a higher rate of serious adverse cardiac events
Patients at Endocrinology Associates who ask about peptide treatment often have specific goals: healing after an injury, training for an event, or staying active without relying on medication
The European Medicines Agencys (EMA) Pharmacovigilance Risk Assessment Committee concluded that no product label update was warranted, based on data from clinical trials, real-world safety monitoring, and electronic health records [45]
This approach removes financial barriers to dose optimizationa key factor in achieving sustained weight loss and minimizing side effects through gradual titration
GLP-2 and GIP exert separate effects on bone turnover: A randomised, placebo-controlled, crossover study in healthy young men